Dr. Ethan Binder, M.D.
Hematology & Oncology (Hematology & Oncology Physician)
2400 Unser Blvd Se
Rio Rancho, NM 87124
Who else practices at this address →
Sandoval County is a federal mental health shortage area; it also includes primary care (11% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Years since graduation
- 14
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 322
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Hematology & Oncology Physician primary
NM license MD2018-0257 -
Internal Medicine Physician
PA license 202497
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Presbyterian Hospital Albuquerque, NM
- Presbyterian Santa Fe Medical Center Santa Fe, NM
- Lincoln County Medical Center Ruidoso, NM
Medical groups
- Presbyterian Healthcare Services (1,395 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 322
- Services billed
- 880
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 351 | 111 |
| Established patient office or other outpatient visit, 30-39 minutes | 217 | 137 |
| Established patient office or other outpatient visit, 20-29 minutes | 94 | 82 |
| New patient office or other outpatient visit, 60-74 minutes | 35 | 35 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 34 | 12 |
| Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 16 | 16 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Letrozole Other prescribers in Rio Rancho, NM | 236 |
| Eliquis (apixaban) Other prescribers in Rio Rancho, NM | 136 |
| Acyclovir Other prescribers in Rio Rancho, NM | 117 |
| Prednisone Other prescribers in Rio Rancho, NM | 117 |
| Prochlorperazine Maleate Other prescribers in Rio Rancho, NM | 115 |
| Sulfamethoxazole-Trimethoprim (sulfamethoxazole/trimethoprim) Other prescribers in Rio Rancho, NM | 114 |
| Abiraterone Acetate | 114 |
| Xarelto (rivaroxaban) Other prescribers in Rio Rancho, NM | 104 |
| Lenalidomide | 102 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Rio Rancho, NM | 100 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 35 payments worth $750 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $129 |
|---|---|
| AbbVie Inc. | $98.50 |
| Celgene Corporation | $68.65 |
| AstraZeneca Pharmaceuticals LP | $62.32 |
| GlaxoSmithKline, LLC. | $46.99 |
| Merck Sharp & Dohme LLC | $45.81 |
| Bayer HealthCare Pharmaceuticals Inc. | $33.39 |
| Pfizer Inc. | $31.47 |
| Food and Beverage | $707 |
|---|---|
| Education | $43.25 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Education ENHERTU · Oncology · in-kind Company’s descriptionJournal Article | $43.25 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.